Ocular Therapeutix Announces Topline Results For Phase 2 Clinical Trial Of OTX-DED For The Short-Term Treatment Of Dry Eye Disease’ Co. Reports ‘Study shows statistically significant improvement for primary endpoint’

by | Dec 6, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.